Global Strategic Account Manager, Seer
$140-160k
This position is also eligible for bonus, benefits, and participation in Company’s equity plan
More information about location
Empowering the scientific community through the power of proteomics
Open for applications
Empowering the scientific community through the power of proteomics
101-200 employees
Open for applications
$140-160k
This position is also eligible for bonus, benefits, and participation in Company’s equity plan
More information about location
101-200 employees
Company mission
To decode the secrets of the proteome to improve human health.
Role
Who you are
- Minimum of 5 years of experience in strategic accounts sales
- Experience with biobank/populations studies is strongly desired
- Successful track record in growing revenue and market share
- Background in entrepreneurial, mission driven selling environments is essential
- Significant experience in life science tools market, including the launch of novel products is preferred
- Advanced knowledge of the life sciences marketplace, key trends, account segments and customer needs
- Advanced degree in sciences, PhD and/or MBA is desirable
- Experience in proteomics is strongly desired
- Exposure to mass spectrometry is strongly desired
- Excellent communication and collaboration skills with the ability to establish positive cross-functional multi-level relationships
- Excellent, influential presentation skills with ability to present complex topics to external stakeholders
What the job involves
- The Global Strategic Account Manager is responsible for securing and managing new Seer customer accounts focused on large-scale population studies and biobanks
- This role is pivotal in driving the growth of our market presence within the population health sector, securing contractual agreements, and contributing to the design and execution of sales strategies and pricing
- This role requires a deep understanding of the population health landscape globally
- Develop and implement a comprehensive sales strategy to penetrate the population health market
- Identify and target key decision-makers to secure new business opportunities
- Collaborate with executive leadership to align sales strategies with organizational goals and market demands
- Establish strong relationships with key stakeholders, including executives and decision-makers at target organizations
- Oversee the process from prospecting to close
- Collaborate with Commercial Leadership and other relevant departments to design effective sales strategies and pricing models tailored to the population health market
- Monitor and analyze sales performance metrics, providing regular reports to the VP of Sales and senior management
- Utilize data and market intelligence to adjust strategies and tactics to meet or exceed sales targets
- Continuously evaluate and improve sales processes and strategies to increase efficiency and effectiveness
- Collaborate with R&D to understand and effectively market the technological advantages of our solutions for large-scale population studies
- Collaborate with STAC groups and Seer centers of excellence in the US and Europe to establish novel solutions for operational execution of large customer studies
- Collaborate with Legal to address any potential compliance issues promptly and effectively
- Travel up to 75% of the time to meet with clients, attend industry events, and support business development activities
Our take
Seer offers tools and solutions that provide unbiased, deep, rapid and large-scale proteomics in the field of biotechnology. More specifically, Seer's life sciences and health data platform helps detect life-threatening diseases before symptoms start to show. The company claims to be able to analyze protein composition in a comparable way to sequencing machines ‘reading’ strands of DNA.
Seer has grown rapidly: the company went public in 2020 after being founded in 2017, and enjoys strong financial backing that has helped it launch a varied range of proteomics products.
Seer faces competition from the likes of Nautilus and Illumina, a multibillion giant in the sequencing world, who have a sub-division dedicated to proteomics. However, Seer has featured on the Deloittes Fast500 2023 and won multiple awards for its innovative product, putting it in good stead to grow rapidly.
Steph
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 5 rounds)
Jul 2020
$55m
SERIES D
Dec 2019
$55m
SERIES D
Total funding: $169.5m
Company benefits
- Family and Medical Leave Act
- Pay Transparency Nondiscrimination Provision
- E-Verify Participation Notice
- Anti-Discrimination Notice/Right to Work
Company HQ
Redwood Shores, Redwood City, CA
Articles
Leadership
Omid Farokhzad
(Chair and CEO)Extensive experience as Chair, Director and Co-founder across multiple companies and technology platforms. Also a graduate of Harvard Medical School.
Share this job
View 2 more jobs at Seer